Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.36 USD | +0.01% | -0.24% | +18.72% |
04-17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
04-09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.72% | 1.37B | |
+26.02% | 661B | |
+27.20% | 566B | |
-6.44% | 352B | |
+20.57% | 332B | |
+3.64% | 283B | |
+14.32% | 231B | |
+5.18% | 200B | |
-9.00% | 195B | |
-4.91% | 145B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals : Q4 Adjusted Earnings Drop, Revenue Rises; Acquires Novitium Pharma for $163.5 Million